1. Resources
  2. Articles
  3. National Natural Science Foundation Hotspot! What is Autophagy?
National Natural Science Foundation Hotspot! What is Autophagy?
Autophagy

Autophagy is a fundamental process that degrades various components within the cell. Autophagy can be non-selective, where cytoplasmic materials are sequestered into autophagosomes for engulfment, typically occurring during nutrient deprivation. In contrast, selective autophagy degrades specific targets, such as damaged organelles: mitophagy, lysophagy, and ER-phagy, playing a crucial role in cellular quality control (Fig. 1)[1][2].

Fig. 1 Different mechanisms of autophagy[2].
2.Autophagy Protects & Promotes Death

Autophagy is a highly integrated process that maintains cellular homeostasis by promoting cell survival or leading to cell death[3][4].

2.1 Autophagy-Mediated Cytoprotection

The primary function of autophagy is to promote cell survival following stress or nutrient deprivation by recycling essential cellular components. Autophagy is induced by various stimuli, including nutrient and energy stress, hypoxia, oxidative stress, and mitochondrial damage[4].

Fig. 2 Overview of the major components of the core pathway of mammalian autophagy[5].

For example, when cells are cultured under conditions of simultaneous nutrient and growth factor deprivation, autophagy reaches its highest level[6]. Additionally, in mice, after 24-48 hours of starvation, most cells in various tissues exhibit an increase in autophagosome numbers[7]. Furthermore, cells must clear damaged mitochondria to prevent the accumulation of reactive oxygen species (ROS)[5]. Certain stress pathways, such as moderate hypoxia, also induce autophagy to prevent cell death (Fig. 2)[5][8].

2.2 Autophagy-Induced Cell Death

Autophagy is often observed in the context of cell death, and in some cases, inhibiting autophagy can prevent cell death[9]. Due to extensive crosstalk between different signaling pathways, the pro-death effects of autophagy are very complex[10].

Case 1: Autophagy-Dependent Ferroptosis

Recently, Jiao Liu and colleagues reported the critical role of TMEM164 in selectively mediating ATG5-dependent autophagosome formation during ferroptosis (rather than during starvation). TMEM164 promotes the death of iron-dependent cells by activating autophagy to degrade ferritin, GPX4, and lipid droplets, thereby increasing iron accumulation and lipid peroxidation. The loss of TMEM164 limits the anticancer activity of ferroptosis-mediated cytotoxicity in mice, establishing a new paradigm for autophagy-dependent ferroptosis[11].

Fig. 3 The role of TMEM164 in autophagy-dependent cell death[11].

Case 2: Autophagy-Triggers Necroptotic Apoptosis

Research indicates that GX15-070 can induce autophagy by increasing the accumulation of autophagosomes and promoting the interaction of Atg5 (a component of the autophagosome membrane) with key components of the necrosome, namely FADD, RIP1, and RIP3, triggering the assembly of the necrosome on autophagosomes. This leads to the formation of cytoplasmic cell death signaling complexes, initiating necrotic cell death[12].

Fig. 4 GX15-070 triggers necroptotic apoptosis by promoting the assembly of the necrosome on autophagosomes[12].

Autophagy plays a dual role in cancer, depending on the type and stage of the cancer[10][13]. On one hand, autophagy can promote tumorigenesis and metastasis; currently, the only FDA-approved autophagy inhibitors are Chloroquine and Hydroxychloroquine[14]. On the other hand, autophagy can enhance the efficacy of cancer treatments by promoting cell death either independently or in conjunction with other cell death pathways (Table 1)[10].

Table 1. Drug treatments that induce autophagy and cell death[10].
3. Detection of Autophagy

With the increasing interest in autophagy research, related detection methods have also become a focal point for researchers. The number of autophagosomes and autophagic flux are often used as indicators of cellular autophagic activity levels.

3.1 Monitoring the Number of Autophagosomes

Currently, there are three main methods used to monitor the number of autophagosomes: electron microscopy, optical microscopy for detecting the subcellular localization of LC3, and biochemical assays for the membrane-associated form of LC3[15].

The most traditional method is electron microscopy, which allows for the observation of autophagic vacuole-like structures in samples. Under electron microscopy, cells undergoing autophagy display damaged organelles, such as swollen mitochondria, surrounded by vacuolar double-membrane-like structures, or double-membranes encircling mitochondria to form autophagosomes. Residual bodies that cannot be degraded are also visible within autolysosomes (Fig. 5 and 6A)[15][16].

Fig 5. Morphology of autophagosomes and autolysosomes[15].

Secondly, the mammalian autophagy protein LC3 is a marker for autophagosomes and can be detected using more widely used optical microscopy and biochemical methods. Endogenous LC3 or GFP-LC3 can be observed via fluorescence microscopy as a diffuse cytoplasmic pool or as punctate structures primarily representing autophagosomes (Fig. 6B-C).

3.2 Monitoring Autophagic Flux

One of the main methods for measuring autophagic flux is monitoring the turnover of LC3. When cells are treated with lysosomal agents (such as ammonium chloride, Chloroquine, or Bafilomycin A1) or lysosomal protease inhibitors (such as E64d), the degradation of LC3-II is blocked, leading to its accumulation. Therefore, the differences in LC3-II levels between samples represent the amount of LC3 delivered to lysosomes for degradation (Fig. 6D)[15].

Fig 6. Methods for monitoring autophagosome quantity and autophagic flux[15].

Additionally, the total cellular LC3 levels can be quantified through immunoblotting analysis or flow cytometry, or qualitatively observed via fluorescence microscopy, which inversely correlates with autophagic flux. Besides LC3, the levels of other autophagic substrates can also be used to monitor autophagic flux (Fig. 6).

Conclusion

In this issue, our little M has summarized the types of cellular autophagy, related mechanisms, and characteristics, and introduced the dual functions of autophagy in cell protection and promotion of cell death. Finally, we have organized the relevant detection methods for cellular autophagy!

Product Recommendation

Chloroquine

Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM).

Hydroxychloroquine

Hydroxychloroquine (HCQ) is a synthetic oral antimalarial drug that can be used in the study of malaria and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Hydroxychloroquine is a potent autophagic flux inhibitor with antiviral activity (such as SARS-CoV-2 virus) that inhibits Toll-like receptor 7/9 (TLR7/9) signaling.

Vorinostat

Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification.

Sorafenib

Sorafenib (Bay 43-9006) is a potent and orally active Raf inhibitor with IC50s of 6 nM and 20 nM for Raf-1 and B-Raf, respectively. Sorafenib is a multikinase inhibitor with IC50s of 90 nM, 15 nM, 20 nM, 57 nM and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit, respectively. Sorafenib induces autophagy and apoptosis. Sorafenib has anti-tumor activity. Sorafenib is a ferroptosis activator.

Dactolisib

Dactolisib (BEZ235) is an orally active and dual pan-class I PI3K and mTOR kinase inhibitor with IC50s of 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR, respectively. Dactolisib (BEZ235) inhibits both mTORC1 and mTORC2.

References
[1] Vargas JNS,et al. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023 Mar;24(3):167-185.
[2] Aman Y,et al. Autophagy in healthy aging and disease. Nat Aging. 2021 Aug;1(8):634-650.
[3] Noguchi M, et al. Autophagy as a modulator of cell death machinery. Cell Death Dis. 2020 Jul 8;11(7):517.
[4] Denton D, et al. Autophagy-dependent cell death. Cell Death Differ. 2019 Mar;26(4):605-616.
[5] Kroemer G, et al. Autophagy and the integrated stress response. Mol Cell. 2010 Oct 22;40(2):280-93.
[6] Boya P, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005 Feb;25(3):1025-40.
[7] Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol. 2010 Apr;22(2):132-9.
[8] Bellot G, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 2009 May;29(10):2570-81.
[9] Jung S, et al. Autophagy as a decisive process for cell death. Exp Mol Med. 2020 Jun;52(6):921-930.
[10] Denton D, et al. Autophagy as a pro-death pathway. Immunol Cell Biol. 2015 Jan;93(1):35-42.
[11] Liu J, et al. TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy. 2023 Mar;19(3):945-956.
[12] Basit F, et al. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ. 2013 Sep;20(9):1161-73.
[13] Li X, et al. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020 Jan 22;19(1):12.
[14] Mohsen S, et al. Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review. Curr Oncol. 2022 Mar 5;29(3):1695-1708.
[15] Mizushima N, et al. Methods in mammalian autophagy research. Cell. 2010 Feb 5;140(3):313-26.
[16] Martinet W, et al. In situ detection of starvation-induced autophagy. J Histochem Cytochem. 2006 Jan;54(1):85-96.